Loading...
Please wait, while we are loading the content...
Similar Documents
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells
| Content Provider | Scilit |
|---|---|
| Author | Gill, Saar Tasian, Sarah Ruella, Marco Shestova, Olga Li, Yong Porter, David L. Carroll, Martin Danet-Desnoyers, Gwenn Scholler, John Grupp, Stephan A. June, Carl H. Kalos, Michael |
| Copyright Year | 2014 |
| Description | Key Points Targeting of CD123 via CAR-engineered T cells results in rejection of human AML and myeloablation in mouse models. |
| Related Links | https://ashpublications.org/blood/article-pdf/123/15/2343/1375412/2343.pdf |
| Ending Page | 2354 |
| Page Count | 12 |
| Starting Page | 2343 |
| DOI | 10.1182/blood-2013-09-529537 |
| Journal | Blood |
| Issue Number | 15 |
| Volume Number | 123 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2014-04-10 |
| Access Restriction | Open |
| Subject Keyword | Research and Experimental Medicine Oncology Human Models Aml Leukemia Antigen Rejection Chimeric Myeloid Cd123 Myeloablation Journal: Blood (Vol- 125, Issue- 15) |
| Content Type | Text |
| Resource Type | Article |